Physician profile
John Guerra
NPI 1093992935
$1,126.13
in general payments reported to CMS, 2019-2025
12 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $236 · 2022: $341 · 2023: $322 · 2024: $72.98 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.22 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $359.18 | 2021-2025 | Jot Dx, Coroflow, Xience Sierra |
| Medtronic, INC. | $309.02 | 2022-2024 | Mycarelink, Azure Xt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $108.17 | 2022-2025 | General - Brady, Zoom Wireless Transmitter, Emblem Mri S-Icd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.62 | 2023 | Lifevest |
| Abiomed | $65.73 | 2025 | |
| Elutia, INC. | $62.19 | 2021 | |
| Philips North America LLC | $55.37 | 2022 | |
| Cardiva Medical, INC. | $32.59 | 2025 | Cardiva Vascade 5f Vcs |
| Terumo Medical Corporation | $23.63 | 2023 | Glidesheath Slender |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2023 | Farxiga |
| Novo Nordisk INC | $14.23 | 2023 | Ozempic, Rybelsus |
| Cardiovascular Systems INC. | $10.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Guerra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.